Zealand Pharma A/S (ZLDPF)
OTCMKTS · Delayed Price · Currency is USD
86.21
-12.70 (-12.84%)
Mar 14, 2025, 10:33 AM EST

Zealand Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
6,1937,0173,2311,4899591,441
Upgrade
Market Cap Growth
117.21%117.21%116.91%55.29%-33.42%13.22%
Upgrade
Enterprise Value
4,9335,7933,0131,5118201,211
Upgrade
Last Close Price
98.91102.3655.6528.1822.0435.95
Upgrade
PS Ratio
806.30806.3063.5599.6957.7745.65
Upgrade
PB Ratio
5.875.8713.6812.706.767.13
Upgrade
P/TBV Ratio
5.875.8713.7812.707.177.48
Upgrade
EV/Sales Ratio
665.70665.7059.28101.1649.4138.39
Upgrade
EV/FCF Ratio
-37.77-----
Upgrade
Debt / Equity Ratio
0.050.050.070.640.850.11
Upgrade
Asset Turnover
0.010.010.190.060.060.11
Upgrade
Inventory Turnover
0.850.850.69-0.12-
Upgrade
Quick Ratio
21.1121.116.236.734.803.71
Upgrade
Current Ratio
21.1421.146.256.735.154.00
Upgrade
Return on Equity (ROE)
-21.13%-21.13%-58.43%-110.75%-70.00%-54.10%
Upgrade
Return on Assets (ROA)
-13.81%-13.81%-19.93%-28.30%-25.53%-23.29%
Upgrade
Return on Capital (ROIC)
-14.80%-14.80%-22.99%-33.41%-31.80%-29.12%
Upgrade
Earnings Yield
-2.42%-2.13%-3.23%-11.60%-16.24%-9.66%
Upgrade
FCF Yield
-2.11%-1.86%-2.01%-9.20%-19.68%-8.14%
Upgrade
Buyback Yield / Dilution
-17.40%-17.40%-22.49%-7.77%-11.73%-13.51%
Upgrade
Total Shareholder Return
-17.40%-17.40%-22.49%-7.77%-11.73%-13.51%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.